Results 151 to 160 of about 3,828 (168)

Ultrarare Muscular Dystrophy Mimics Facioscapulohumeral Muscular Dystrophy

Pediatric Neurology
Bret J. Gardner, Meeta Cardon
openaire   +2 more sources

Facioscapulohumeral Muscular Dystrophy

American Journal of Physical Medicine & Rehabilitation, 1995
David D. Kilmer, Richard T. Abresch, Megan A. McCrory, Gregory T. Carter, William M. Fowler, E Ralph Johnson, Craig M. McDonald   +6 more
openaire   +1 more source

The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy

Annual Review of Genomics and Human Genetics, 2019
Peter Jones, Charis L Himeda
exaly  

Facioscapulohumeral muscular dystrophy

Journal of Neurology, 2003
Miriam Butz, M. C. Koch, W. Muller-Felber, R. J. L. F. Lemmers, S. M. van der Maarel, H. Schreiber   +5 more
openaire   +1 more source

Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress

Neuromuscular Disorders, 2003
Rabi Tawil, Sara T Winokur, Denise A Figlewicz   +2 more
exaly  

Molecular diagnosis of facioscapulohumeral muscular dystrophy

Expert Review of Molecular Diagnostics, 2002
Meena Upadhyaya, David N Cooper
exaly  

Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review

International Journal of Molecular Sciences, 2020
Tai-Heng Chen
exaly  

Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1

PLoS ONE, 2015
David Bendahan, Emmanuelle Salort-Campana, Badih Ghattas   +2 more
exaly  

Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy

Proceedings of the National Academy of Sciences of the United States of America, 2020
Toshifumi Yokota, Kenji Rowel Q Lim, Rika Maruyama   +2 more
exaly  

Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy

Molecular Therapy, 2018
Takako Jones, Michael R Green, Peter Jones   +2 more
exaly